Product
T8
Aliases
Leiteng Shu
2 clinical trials
2 indications
Indication
HealthyClinical trial
Efficacy and Safety of T8 on Treating Chronic Abnormal Immune Activation in HIV/AIDS Patients: A Multicenter, Randomized, Double-blind, Dose-finding, Placebo-controlled StudyStatus: Completed, Estimated PCD: 2022-07-05
Clinical trial
Formulation Selection and Subsequent Optimization of Oral Formulations of BI 685509 in Healthy Male Subjects (Open-label, Randomized, Single-dose Design Study in up to Three Parts; Trial Part 1: Five-period Crossover; Optional Trial Parts 2 & 3: Fourperiod Crossover)Status: Completed, Estimated PCD: 2022-02-07